open access
Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours
Affiliations- Department and Clinic of Oncology, Medical University of Gdansk, Poland
- Department of General, Oncological and Gastroenterological Surgery and Transplantology, University Hospital, Jagiellonian University in Krakow, Poland
- Oncological Surgery Clinic, Oncology Centre in Bydgoszcz, Poland
- General and Colorectal Surgery Clinic, Medical University in Lodz, Poland
- National Consultant for General Surgery
- Oncological Surgery Clinic, Medical University in Lodz, Poland. National Consultant for Oncological Surgery
- General, Oncological and Vascular Surgery Clinic, 5th Military Hospital with a Polyclinic in Krakow, Poland
- Department of General, Gastroenterological and Oncological Surgery, Nicolaus Copernicus University in Torun, Poland
- Surgical Oncology Department, Lower Silesian Oncology Centre in Wroclaw, Poland
- Surgical Department and Clinic of Oncological Gastroenterology – National Research Institute of Oncology, Warsaw, Poland
- Department and Clinic of Oncological Surgery Clinic, Medical University in Lublin, Poland
- Oncology and Radiotherapy Clinic – National Research Institute of Oncology, Warsaw, Poland
- Oncological Gynaecology Chair and Clinic, Medical University of Gdansk, Poland
- Department and Chair of Pathomorphology, Medical University of Gdansk, Poland
- Department of Surgery and Urology for Children and Adolescents, Medical University of Gdansk, Poland
- Department of Radiology, Medical University of Gdansk, Poland
- Department and Clinic of Anaesthesiology and Intensive Care, Medical University of Gdansk, Poland
open access
Abstract
Surgical treatment of patients with peritoneal metastases in combination with Hyperthermic intraperitoneal Chemotherapy (HIPEC) and systemic treatments is applied with increasing frequency and, with correct patient qualification, allows for obtaining 5-year survival at a level of 32–52%. The conditions necessary for positive results of such treatment include the high experience of a given centre, its appropriate infrastructure, and appropriate patient qualification for the procedure. As a result of the debate connected with the need to evaluate treatment quality and results, at the request of the Peritoneal Cancer Section of the Polish Society of Oncological Surgery, the conditions for quality assurance were worked out and a Quality Assurance Commission was set up for the centres performing cytoreductive procedures and HIPEC procedures in the treatment of primary and secondary peritoneal tumours.
Abstract
Surgical treatment of patients with peritoneal metastases in combination with Hyperthermic intraperitoneal Chemotherapy (HIPEC) and systemic treatments is applied with increasing frequency and, with correct patient qualification, allows for obtaining 5-year survival at a level of 32–52%. The conditions necessary for positive results of such treatment include the high experience of a given centre, its appropriate infrastructure, and appropriate patient qualification for the procedure. As a result of the debate connected with the need to evaluate treatment quality and results, at the request of the Peritoneal Cancer Section of the Polish Society of Oncological Surgery, the conditions for quality assurance were worked out and a Quality Assurance Commission was set up for the centres performing cytoreductive procedures and HIPEC procedures in the treatment of primary and secondary peritoneal tumours.
Keywords
quality assurance; cytoreduction; HIPEC; treatment quality; peritoneal cancers
About this articleTitle
Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Guidelines / Expert consensus
Pages
85-91
Published online
2020-06-16
Page views
929
Article views/downloads
775
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2020;70(3):85-91.
Keywords
quality assurance
cytoreduction
HIPEC
treatment quality
peritoneal cancers
Authors
Tomasz Jastrzębski
Piotr Richter
Wojciech Zegarski
Adam Dziki
Grzegorz Wallner
Arkadiusz Jeziorski
Wojciech M. Wysocki
Marek Jackowski
Marek Bębenek
Tomasz Olesiński
Wojciech Polkowski
Lucjan Wyrwicz
Dariusz Wydra
Wojciech Biernat
Piotr Czauderna
Michał Studniarek
Tomasz Polec
Radosław Owczuk
Anna Sommer
Krzysztof Szewczyk
Jerzy Mielko